This map shows the geographic impact of Mesut Çetin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mesut Çetin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mesut Çetin more than expected).
This network shows the impact of papers produced by Mesut Çetin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mesut Çetin. The network helps show where Mesut Çetin may publish in the future.
Co-authorship network of co-authors of Mesut Çetin
This figure shows the co-authorship network connecting the top 25 collaborators of Mesut Çetin.
A scholar is included among the top collaborators of Mesut Çetin based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Mesut Çetin. Mesut Çetin is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Çetin, Mesut & Feyza Arıcıoğlu. (2010). Pharmacoeconomics and its importance in psychiatry. SHILAP Revista de lepidopterología. 20(1). 1–4.1 indexed citations
11.
Çetin, Mesut & Feyza Arıcıoğlu. (2009). On the debate of original drug versus generic drug. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(3). 211–213.2 indexed citations
12.
Çetin, Mesut & Selim Kılıç. (2009). How to comprehend the recent meta-analyses conducted on typical and atypical antipsychotics?. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(1). 1–4.3 indexed citations
13.
Çetin, Mesut & Cengizhan Açıkel. (2009). In perspective of meta-analyses: Are all of the antidepressants similar?. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 19(2). 87–92.4 indexed citations
14.
Çetin, Mesut. (2008). Antidepressants, antipsychotics: Reliability of metaanalyses -. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 18(4). 245–250.5 indexed citations
15.
Dılbaz, Nesrin, Oğuz Karamustafalıoğlu, Timuçin Oral, Emin Önder, & Mesut Çetin. (2006). Evaluation of compliance to treatment and factors affecting compliance for schizophrenia outpatients. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 16(4). 223–232.7 indexed citations
16.
Semiz, Ümit Başar, et al.. (2005). Body dysmorphic disorder, trauma, and dissociation in patients with borderline personality disorder: a preliminary study -. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 15(2). 65–70.3 indexed citations
17.
Ebrinç, Servet, Mesut Çetin, & Özgür Öner. (2004). Atypical antipsychotics in treatment of bipolar disorderin special populations. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 14(4). 236–250.1 indexed citations
18.
Ebrinç, Servet, et al.. (2004). Efficacy and safety of amisulpride treatment in schizophrenia: Comparisonwith haloperidol. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 14(3). 143–149.3 indexed citations
19.
Ebrinç, Servet, et al.. (2002). The efficacy and safety of haloperidol and risperidone in patients with schizophrenia. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 12(1). 6–13.2 indexed citations
20.
Çetin, Mesut & Atilla Turgay. (2002). Antipsychotic Treatment In The Fiftieth Year Of Modern Psychopharmacology: An Update -. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology. 12(4). 211–226.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.